Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-030852
Filing Date
2021-05-28
Accepted
2021-05-28 17:16:44
Documents
4
Effectiveness Date
2021-05-28

Document Format Files

Seq Description Document Type Size
1 S-8 lvtx-s8.htm S-8 211954
2 EX-5.1 lvtx-ex51_46.htm EX-5.1 80625
3 EX-23.1 lvtx-ex231_47.htm EX-23.1 2774
4 GRAPHIC g1piribkwhvg000001.jpg GRAPHIC 8824
  Complete submission text file 0001564590-21-030852.txt   308687
Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256655 | Film No.: 21981644
SIC: 2834 Pharmaceutical Preparations